Gene · 6839
Papers3,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,741 to 1,760 of 3,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of dual reading domains as novel reagents in chromatin biology reveals a new H3K9me3 and H3K36me2/3 bivalent chromatin state. | Epigenetics Chromatin | 2017 | 28946896 | PubTator, text mining | PubMed |
| HP1α is highly expressed in glioma cells and facilitates cell proliferation and survival. | Cancer Biomark | 2017 | 28946550 | PubTator, text mining | PubMed |
| Modular fluorescence complementation sensors for live cell detection of epigenetic signals at endogenous genomic sites. | Nat Commun | 2017 | 28935858 | PubTator, text mining | PubMed |
| Heterochromatin Reduction Correlates with the Increase of the KDM4B and KDM6A Demethylases and the Expression of Pericentromeric DNA during the Acquisition of a Transformed Phenotype. | J Cancer | 2017 | 28928876 | PubTator, text mining | PubMed |
| Major transcriptional changes observed in the Fulani, an ethnic group less susceptible to malaria. | Elife | 2017 | 28923166 | PubTator, text mining | PubMed |
| Rapid and reversible epigenome editing by endogenous chromatin regulators. | Nat Commun | 2017 | 28916764 | PubTator, text mining | PubMed |
| MicroRNA expression profiles and networks in placentas complicated with selective intrauterine growth restriction. | Mol Med Rep | 2017 | 28901463 | PubTator, text mining | PubMed |
| The future: genetics advances in MEN1 therapeutic approaches and management strategies. | Endocr Relat Cancer | 2017 | 28899949 | PubTator, text mining | PubMed |
| The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer. | Oncotarget | 2017 | 28881702 | PubTator, text mining | PubMed |
| Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma. | Hum Mutat | 2017 | 28881068 | PubTator, text mining | PubMed |
| Epigenetic Matters: The Link between Early Nutrition, Microbiome, and Long-term Health Development. | Front Pediatr | 2017 | 28879172 | PubTator, text mining | PubMed |
| Correction: Impact of nucleic acid and methylated H3K9 binding activities of Suv39h1 on its heterochromatin assembly. | Elife | 2017 | 28874256 | PubTator, text mining | PubMed |
| SUMO, a small, but powerful, regulator of double-strand break repair. | Philos Trans R Soc Lond B Biol Sci | 2017 | 28847818 | PubTator, text mining | PubMed |
| New roles for Dicer in the nucleolus and its relevance to cancer. | Cell Cycle | 2017 | 28846478 | PubTator, text mining | PubMed |
| Tumor cell senescence response produces aggressive variants. | Cell Death Discov | 2017 | 28845296 | PubTator, text mining | PubMed |
| Downregulation of PARP1 transcription by promoter-associated E2F4-RBL2-HDAC1-BRM complex contributes to repression of pluripotency stem cell factors in human monocytes. | Sci Rep | 2017 | 28842672 | PubTator, text mining | PubMed |
| Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression. | Sci Rep | 2017 | 28839265 | PubTator, text mining | PubMed |
| Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia. | Environ Mol Mutagen | 2017 | 28833505 | PubTator, text mining | PubMed |
| Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B. | Hepatology | 2017 | 28833361 | PubTator, text mining | PubMed |
| Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3. | Stem Cell Reports | 2017 | 28826853 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6839/papers?page=88